Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Solid Phase Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced Fmoc solid-phase synthesis for Triptorelin bulk drug. Patent CN103012565A offers high yield, low racemization, and scalable manufacturing for reliable supply chains.
Patent CN102190709A details a novel two-fragment solid-phase synthesis for LH-RH derivatives, offering high purity and cost-effective manufacturing solutions.
Patent CN103087177A details microwave-assisted solid-phase synthesis of stable GLP-1 analogues with extended half-life, offering cost-effective manufacturing solutions.
Novel patent CN119823209A enables high-purity cyclic peptide production with reduced side reactions and improved supply chain reliability for pharmaceutical intermediates.
Novel solid-phase synthesis of Teixobactin analogs via copper-mediated cyclization. Reduces steps and cost for antibiotic manufacturing.
Novel solid-phase synthesis method for Apraglutide improves yield and purity. Reduces hydrophobic aggregation issues for reliable pharmaceutical intermediate supply.
Patent CN116425824A reveals a novel solid-phase method for S-2732 synthesis. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable processes.
Patent CN104371010B details a safer Fmoc solid-phase synthesis for Ganirelix. This method improves yield and purity while eliminating toxic HF usage for reliable supply.
Patent CN102775471B details a hybrid synthesis for Cholecystokinin Octapeptide. This method offers high purity, avoids hazardous HF, and ensures scalable API intermediate production.
Patent CN101357937A details an efficient Fmoc-based SPPS route for Atosiban, offering high purity and reduced waste for pharmaceutical manufacturing.
Advanced preparation of Desmopressin Acetate via solid-phase synthesis and liquid-phase oxidation. High purity, scalable process for reliable pharmaceutical intermediates supply.
Novel cyclic peptide patent CN109897091A offers high stability against Candida albicans. Reliable supplier for scalable pharmaceutical intermediate manufacturing.
Patent CN104628826A details a high-yield Linaclotide method. This report analyzes supply chain benefits and cost reduction in API manufacturing for procurement teams.
Patent CN108484735A details solid-phase synthesis of cyclic heptapeptides. Offers high purity, scalable production, and cost-effective marine drug intermediate manufacturing solutions.
Patent CN103554226B details all-solid-phase synthesis for alpha-conotoxin MI. Enhances purity and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel solid-phase method improves purity and yield significantly. Reduces impurities and production costs for scalable manufacturing of cardiovascular drugs.
Patent CN101712716B details a solid-phase iodine oxidation method for Vapreotide, improving yield and purity while simplifying manufacturing for reliable supply chains.
Patent CN104311639A details improved solid-phase synthesis for Somatostatin. Enhances purity and yield while reducing oxidation risks for supply chain stability.
Patent CN102816211B details a high-yield Fmoc solid-phase synthesis for Afamelanotide, offering safer production and cost reduction in pharmaceutical manufacturing.
Patent CN105646675B details efficient solid-phase synthesis of Coibamide A analogues. Enhances yield and purity for reliable pharmaceutical intermediate supply chains.